Alpha-Gal Bound Aptamer and Vancomycin Synergistically Reduce Staphylococcus aureus Infection In Vivo

Methicillin-resistant Staphylococcus aureus (MRSA) is a pervasive and persistent threat that requires the development of novel therapies or adjuvants for existing ones. Aptamers, small single-stranded oligonucleotides that form 3D structures and can bind to target molecules, provide one possible the...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, Matthew K., Shaw, Claire, Woods, Leslie, Weimer, Bart C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383818/
https://www.ncbi.nlm.nih.gov/pubmed/37512948
http://dx.doi.org/10.3390/microorganisms11071776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383818/
https://www.ncbi.nlm.nih.gov/pubmed/37512948
http://dx.doi.org/10.3390/microorganisms11071776

Ejemplares similares